Kay Bishop, MD
Dermatology · Rigby, IDNPI 1699764209
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 8 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 5 manufacturers reported payments, led by Lilly USA, LLC at 41.3% of the total. That places this record below the midpoint for dermatology clinicians in ID, where the typical reported total is $2,238.
Across 8 payments — averaging $23.76 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Lilly USA, LLC$79
- LEO Pharma Inc.$43
- AbbVie$31
- Johnson & Johnson$20
- UCB, Inc.$17
What the payments were for
- Food & beverage$190100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Lilly USA, LLC | 2 | $79 |
| LEO Pharma Inc. | 2 | $43 |
| AbbVie | 2 | $31 |
| Johnson & Johnson | 1 | $20 |
| UCB, Inc. | 1 | $17 |
How this compares
$190 in reported general payments places this provider in the 10th percentile of 52 dermatology providers in Idaho.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Fluorouracil | 60 | $6,931 |
| CiclopiroxCiclopirox Olamine | 53 | $2,124 |
| Minocycline Hcl | 66 | $1,578 |
| Dapsone | 11 | $1,275 |
| Clobetasol Propionate | 25 | $729 |
| Imiquimod | 28 | $717 |
| Metronidazole | 11 | $565 |
| Triamcinolone Acetonide | 73 | $552 |
| Doxepin Hcl | 21 | $451 |
| ValacyclovirValacyclovir Hcl | 31 | $434 |
| Hydrocortisone | 16 | $162 |
| Gabapentin | 26 | $148 |
| Mupirocin | 21 | $135 |
| Fluoxetine Hcl | 17 | $118 |
| Azithromycin | 17 | $118 |
Paid to pharmacies, not to this prescriber.
Other dermatology in Rigby
- Alan OlmsteadTwin Falls$405K
- Dustin PortelaBoise$164K
- Steven MingsBoise$82K
- Ryan HarrisMeridian$58K
- Jeffrey DraluckNorthbrook$36K
- Mark SchwendimanMeridian$9K
- Ryan OwsleyNampa$9K
- Kelsey FerrellMeridian$6K
- Nicholas BlickenstaffBoise$6K
- Randall BurrMeridian$5K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.